- Doctors dosed a healthy volunteer on Monday with an antibody treatment developed by Eli Lilly and Chinese company Junshi Biosciences to fight COVID-19.
Scientists will first test to see if this antibody treatment, called JS016, is safe to be used in humans. If so, it will be tested to see if it if effective.The companies will also experiment to see if the antibody could be used on its own or if it would be more effective used in combination with other antibody candidates. JS016 appeared to neutralize the virus in the lab. Lilly and Junshi scientists are testing other potential antibodies in the lab to see which work best.
Junshi Biosciences is leading development in greater China, according to Lilly, and Eli Lilly has exclusive rights to it in the rest of the world. Antibodies are proteins your body makes in the thousands that naturally fight off infection. To make an antibody therapy, scientists have to sort through thousands of antibodies to determine which work best to neutralize a particular threat.
eli lilly is a prestigious pharma company. junshi biosciences never heard. baka malagay lang tayo sa alanganin. alam mo na basta gawa ng china mawewendang ka talaga. covid-19 antibody treatment pa!
Philippines Latest News, Philippines Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: cebudailynews - 🏆 8. / 71 Read more »
Source: manilabulletin - 🏆 25. / 51 Read more »
Source: ANCALERTS - 🏆 26. / 50 Read more »
Source: cebudailynews - 🏆 8. / 71 Read more »
Source: ABSCBNNews - 🏆 5. / 83 Read more »
Source: gmanetwork - 🏆 12. / 63 Read more »